ArticlePharmaceutical research2012

Surface-engineered nanoliposomes by chelating ligands for modulating the neurotoxicity associated with β-amyloid aggregates of Alzheimer's disease.

Maluta S Mufamadi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.